GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples

$615,433
Tony Y. Hu · Tulane University Of Louisiana · U01 · FY2021 · CA

Detecting cancer early with targeted nano-probes for vascular signatures

$615,218
Douglas Hanahan · University Of California, San Francisco · R01 · FY2007 · CA

Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy

$615,194
Issam M. El Naqa · University Of Michigan At Ann Arbor · R37 · FY2018 · CA

DIRAS3 disrupts K-RAS clustering and signaling, enhancing autophagy and response to autophagy inhibition

$615,047
Robert C Bast · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Genotyping for epidemiology studies

$614,909
Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA

Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance

$614,870
Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2017 · CA

Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy

$614,801
Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA

Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

$614,787
Peter J Allen · Duke University · R01 · FY2021 · CA

Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer

$614,511
Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2020 · CA

Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic Hyperthermia

$614,464
Oleh Taratula · Oregon State University · R01 · FY2021 · CA

Therapeutic Targeting Mitochondrial C1 Metabolism

$614,438
Larry H. Matherly · Wayne State University · R01 · FY2025 · CA

Protein and proteolytic activity biomarkers of early stage pancreatic cancer

$614,311
Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Ultrasound enhanced penetration for treatment of pancreatic cancer

$614,273
Joo H Hwang · University Of Washington · R01 · FY2011 · CA

Histidine phosphorylation as a new target for cancer therapy

$614,254
Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2019 · CA

Innovative mRNA vaccines to enhance the efficacy of T-cell transfer therapies against solid tumors

$614,124
Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2025 · CA

Targeting LIF/LIFR in pancreatic cancer

$614,006
Hareesh Babu Nair · Evestra, Inc. · R44 · FY2020 · CA

Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation

$613,967
Bart C De Jonghe · University Of Pennsylvania · R01 · FY2024 · DK

Adoptive T Cell Therapy for Pancreatic Cancer

$613,867
Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Patient-specific, high-sensitivity spectral CT for assessment of pancreatic cancer

$613,764
Peter B Noã‹l · University Of Pennsylvania · R01 · FY2022 · EB

CANCER GRAND CHALLENGES 2024 SOCIETAL, ANCESTRY, MOLECULAR AND BIOLOGICAL ANALYSES OF INEQUALITIES (SAMBAI) Morehouse School of Medicine

$613,542
Melissa B Davis · Morehouse School Of Medicine · OT2 · FY2024 · CA

A multimodal imaging system and targeted nanoprobes for image-guided treatment of breast cancer

$613,368
Huabei Jiang · University Of South Florida · R01 · FY2019 · EB

The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor

$613,156
Aatur Dilip Singhi · University Of Pittsburgh At Pittsburgh · R37 · FY2021 · CA

Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance

$613,017
Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2021 · CA

Inhibiting Multi-Functional ALDOA for Cancer Therapy

$612,848
Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · CA

Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model

$612,841
Ryan C Fields · Washington University · R01 · FY2020 · CA